Please assess the completion status of the following clinical trial:

Trial Title: Prevention of Intraoperative Nausea and Vomiting During Cesarean Section

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* English speaking ASA I-II non-laboring women with single gestations ≥36 weeks~* Scheduled or unscheduled cesarean delivery under spinal anesthesia~* Height: 5 feet-5 feet 11 in.~Exclusion Criteria:~* Laboring women needing an emergency cesarean delivery~  * Subjects less than 18 years of age~ * Receipt of a drug with antiemetic properties in the 24 hours prior to cesarean section~ * Allergy to ondansetron, or metoclopramide~ * Severe hypertensive disease of pregnancy defined as systolic blood pressure (SBP)\>160mmHg, diastolic blood pressure (DBP)\>110mmHg requiring antihypertensive treatment or associated with significant proteinuria.~ * Severe Cardiac disease in pregnancy with marked functional limitations~ * Diabetes type I~ * Patients on Monoamine Oxidase Inhibitors or Tricyclic Antidepressants~ * Morbid obesity (body mass index (BMI)\>45)~ * Inclusion in another anesthetic study involving drug administration

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- Metoclopramide (Type: ACTIVE_COMPARATOR): Prophylaxis with metoclopramide and phenylephrine infusion.
- Phenylephrine infusion (Type: PLACEBO_COMPARATOR): Prophylactic phenylephrine infusion and placebo antiemetics
- Combination Group (Type: ACTIVE_COMPARATOR): Metoclopramide and Ondansetron prophylaxis with phenylephrine infusion

Based on this trial design, predict the completion outcome and termination type (if applicable).